Product analysis
Wellness ImmuNitric combines B vitamins with arginine and citrulline for nutritional and blood-flow support. The arginine offers good value, while citrulline is expensive for the amount supplied.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality34
The relative quality of the named vitamin and arginine forms remains uncertain. Citrulline's form is unnamed, limiting a clear comparison of that ingredient.
Ingredient Transparency65
All listed amounts are disclosed, but some ingredient forms are missing. Folate's source proportions are also unclear, limiting a complete comparison of the mixture.
Value For Money44
Arginine offers good value, while citrulline is expensive for the amount supplied. Uncertainty around vitamin and sodium value prevents a firm cost judgment for the whole formula.
Customer Satisfaction68
The available ratings are generally positive, but the customer group is small. That gives only a limited picture of satisfaction and does not establish improved energy or circulation.
Product Focus71
The vitamins address nutritional needs, while the amino acids have a separate blood-flow purpose. Citrulline has limited vascular findings, but its serving is below usual trial amounts and arginine's benefits remain inconsistent.
- Format
Tablet - Container
- 90 Tablet(s)
- Per serving
- $0.43
- Customer rating
- 4.6 · 26 ratings
Goals
Folate and vitamin B6 support homocysteine metabolism without establishing cardiovascular-event prevention. Citrulline has limited blood-pressure findings from small trials, but the 750 mg serving is below their usual exposures. Declared arginine is a nitric-oxide precursor with inconsistent routine vascular benefits. A separate L-arginine entry remains unresolved and adds no confirmed dose.
How this product is rated for Cardiovascular Support
Ingredient fit70
Goal fit
Dose adequacy
Pathways69
Depth
Breadth
Evidence79
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Folate and vitamin B6 support normal nutrient functions and can help address tiredness associated with low intake. Arginine and L-citrulline contribute to the saved blood-flow findings, but arginine's performance evidence is inconsistent and citrulline findings are exercise-specific. The small pure L-citrulline amount should not inherit results from larger citrulline-malate exposures. Nutritional support and exercise effects remain separate expectations.
How this product is rated for Energy
Ingredient fit84
Goal fit
Dose adequacy
Pathways45
Depth
Breadth
Evidence66
Evidence strength
Studied preparation
Formulation logic100
Partner coverage
Conflicts
Effective doses
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Calories | 20 Calorie(s) | |
Vitamin B6 (Pyridoxine Hydrochloride) | 7.5 mg | |
Folate (Calcium Folinate, Folic Acid) | 420 mcg DFE | |
Sodium | 10 mg | |
L-Arginine (L-Arginine Hydrochloride) | 2250 mg | |
L-Citrulline | 750 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability70
Arginine Form & Sourcing Purity
Dose, Safety & Label Transparency85
Arginine Dose Per Serving
Value80
Price Per Gram of Arginine
How this ingredient is rated
Active Ingredient Quality & Bioavailability70
Citrulline Form Specificity
Purity and Sourcing Markers
Dose, Safety & Label Transparency64
L-Citrulline Dosage Efficacy
Label Clarity and Transparency
Value0
Price per Gram of L-Citrulline
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Reassessment of the effect of oral l-arginine on blood pressure: A systematic review and meta-analysis based on ambulatory blood pressure monitoring.
- Effect of Long-Term L-Arginine Supplementation on Arterial Compliance and Metabolic Parameters in Patients with Multiple Cardiovascular risk Factors: Randomized, Placebo-Controlled Study.
- Increase in fasting vascular endothelial function after short-term oral L-arginine is effective when baseline flow-mediated dilation is low: a meta-analysis of randomized controlled trials.
- L-arginine improves endothelial function and reduces LDL oxidation in patients with stable coronary artery disease.
- Oral L-Arginine Administration Improves Anthropometric and Biochemical Indices Associated With Cardiovascular Diseases in Obese Patients: A Randomized, Single Blind Placebo Controlled Clinical Trial.
- Does l-citrulline supplementation and watermelon intake reduce blood pressure in middle-aged and older adults? A systematic review and meta-analysis of randomized controlled trials.
- Micronutrient Supplementation to Reduce Cardiovascular Risk.
- l-Citrulline supplementation improves O2 uptake kinetics and high-intensity exercise performance in humans.
- Effects of L-Citrulline Supplementation on Endothelial Function and Blood Pressure in Hypertensive Postmenopausal Women.
- Short-term effects of L-citrulline supplementation on arterial stiffness in middle-aged men.
- Associations of dietary folate, vitamin B6 and B12 intake with cardiovascular outcomes in 115664 participants: a large UK population-based cohort.
- Folate, Homocysteine, and Adverse Outcomes After Ischemic Stroke.
- Effect of folic acid on endothelial function following acute myocardial infarction.
- Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial.
- 5-methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia.
- Association between serum pyridoxal 5'-phosphate levels and all-cause, cardiovascular mortality, and cardiovascular disease in adults: a population-based cohort study.
- Folate and vitamin B6 rapidly normalize endothelial dysfunction in children with type 1 diabetes mellitus.
- Pyridoxine improves endothelial function in cardiac transplant recipients.
- Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women.
- Efficacy and safety of pyridoxal 5'-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial.